Jul 14, 2022 / NTS GMT
Matts Johansen - Aker BioMarine ASA - CEO
Good morning, and welcome to Aker BioMarine's second-quarter presentation, where myself and CFO, Katrine Klaveness will take you through the numbers from the quarter, as well as the highlights. We'll have a section at the end for Q&A, and you can already now start to email your questions at [email protected]. And I believe you will see the e-mail address at the bottom of your screen throughout the presentation as well.
I'm very pleased with the performers of the second quarter as well as the outlook for the rest of the year. Our revenue ended on par with the same quarter last year, but with significant growth from the previous quarter. Our EBITDA of $21.4 million shows good growth from the second quarter last year, as well as significant growth from the previous quarter.
I'm also happy to report positive numbers, black numbers at the bottom line, with $15 million in net profit. On the ingredients side, we experienced strong growth, both in volume and prices, for our Qrill segment; while our Superba segment's been impacted by some of those
Q2 2022 Aker Biomarine ASA Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers